Mucosal administration of HC peptides resulted in decreased gastric inflammation and reduced circulating amounts of the pro-inflammatory cytokine IL-1β in rats with stress-induced ulcers and acetic acid-induced ulcers [34,37]. Here, IL1B is linked to ulcer disease.